153 related articles for article (PubMed ID: 23072840)
1. Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.
Alberti S; Ambrogi F; Boracchi P; Fornili M; Querzoli P; Pedriali M; La Sorda R; Lattanzio R; Tripaldi R; Piantelli M; Biganzoli E; Coradini D
Jpn J Clin Oncol; 2012 Dec; 42(12):1128-37. PubMed ID: 23072840
[TBL] [Abstract][Full Text] [Related]
2. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.
Schmidt M; Hasenclever D; Schaeffer M; Boehm D; Cotarelo C; Steiner E; Lebrecht A; Siggelkow W; Weikel W; Schiffer-Petry I; Gebhard S; Pilch H; Gehrmann M; Lehr HA; Koelbl H; Hengstler JG; Schuler M
Clin Cancer Res; 2008 Sep; 14(18):5849-55. PubMed ID: 18794096
[TBL] [Abstract][Full Text] [Related]
3. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.
Spizzo G; Went P; Dirnhofer S; Obrist P; Simon R; Spichtin H; Maurer R; Metzger U; von Castelberg B; Bart R; Stopatschinskaya S; Köchli OR; Haas P; Mross F; Zuber M; Dietrich H; Bischoff S; Mirlacher M; Sauter G; Gastl G
Breast Cancer Res Treat; 2004 Aug; 86(3):207-13. PubMed ID: 15567937
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
[TBL] [Abstract][Full Text] [Related]
5. Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.
Schmidt M; Petry IB; Böhm D; Lebrecht A; von Törne C; Gebhard S; Gerhold-Ay A; Cotarelo C; Battista M; Schormann W; Freis E; Selinski S; Ickstadt K; Rahnenführer J; Sebastian M; Schuler M; Koelbl H; Gehrmann M; Hengstler JG
Breast Cancer Res Treat; 2011 Feb; 125(3):637-46. PubMed ID: 20352488
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
Spizzo G; Went P; Dirnhofer S; Obrist P; Moch H; Baeuerle PA; Mueller-Holzner E; Marth C; Gastl G; Zeimet AG
Gynecol Oncol; 2006 Nov; 103(2):483-8. PubMed ID: 16678891
[TBL] [Abstract][Full Text] [Related]
8. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients.
Srivastava G; Assi J; Kashat L; Matta A; Chang M; Walfish PG; Ralhan R
BMC Cancer; 2014 Sep; 14():726. PubMed ID: 25265904
[TBL] [Abstract][Full Text] [Related]
10. TROP-1/Ep-CAM and CD24 are potential candidates for ovarian cancer therapy.
Wang G; Zhang Z; Ren Y
Int J Clin Exp Pathol; 2015; 8(5):4705-14. PubMed ID: 26191160
[TBL] [Abstract][Full Text] [Related]
11. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker.
Stoecklein NH; Siegmund A; Scheunemann P; Luebke AM; Erbersdobler A; Verde PE; Eisenberger CF; Peiper M; Rehders A; Esch JS; Knoefel WT; Hosch SB
BMC Cancer; 2006 Jun; 6():165. PubMed ID: 16796747
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
13. Ep-CAM overexpression in breast cancer as a predictor of survival.
Gastl G; Spizzo G; Obrist P; Dünser M; Mikuz G
Lancet; 2000 Dec; 356(9246):1981-2. PubMed ID: 11130529
[TBL] [Abstract][Full Text] [Related]
14. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
[TBL] [Abstract][Full Text] [Related]
16. Expression of Ep-CAM, but not of E48, associates with nodal involvement in advanced squamous cell carcinomas of the larynx.
Romeu C; Farré X; Cardesa A; Nadal A
Histopathology; 2013 May; 62(6):954-61. PubMed ID: 23672314
[TBL] [Abstract][Full Text] [Related]
17. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
Piyathilake CJ; Frost AR; Weiss H; Manne U; Heimburger DC; Grizzle WE
Hum Pathol; 2000 Apr; 31(4):482-7. PubMed ID: 10821496
[TBL] [Abstract][Full Text] [Related]
18. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
Akita H; Nagano H; Takeda Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Takahashi H; Ohigashi H; Tomita Y; Ishikawa O; Mori M; Doki Y
Oncogene; 2011 Aug; 30(31):3468-76. PubMed ID: 21399662
[TBL] [Abstract][Full Text] [Related]
19. Trop-2 is a determinant of breast cancer survival.
Ambrogi F; Fornili M; Boracchi P; Trerotola M; Relli V; Simeone P; La Sorda R; Lattanzio R; Querzoli P; Pedriali M; Piantelli M; Biganzoli E; Alberti S
PLoS One; 2014; 9(5):e96993. PubMed ID: 24824621
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.
Varga M; Obrist P; Schneeberger S; Mühlmann G; Felgel-Farnholz C; Fong D; Zitt M; Brunhuber T; Schäfer G; Gastl G; Spizzo G
Clin Cancer Res; 2004 May; 10(9):3131-6. PubMed ID: 15131054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
